These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21544823)

  • 1. A randomized, quadruple crossover single-blind study on immediate action of chewed and unchewed low-dose acetylsalicylic acid tablets in healthy volunteers.
    Sai Y; Kusaka A; Imanishi K; Matsumoto M; Takahashi R; Sugimoto N; Sugama J; Anada T; Asakura H; Miyamoto K
    J Pharm Sci; 2011 Sep; 100(9):3884-91. PubMed ID: 21544823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution.
    Feldman M; Cryer B
    Am J Cardiol; 1999 Aug; 84(4):404-9. PubMed ID: 10468077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
    Schwertner HA; McGlasson D; Christopher M; Bush AC
    Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet.
    Atar D; Sarkar S; Kolev E; Mura C; Brosstad F; Theodorsen L; Westen GI; Stribolt-Halvorsen PE
    Int J Clin Pharmacol Ther; 2022 Oct; 60(10):430-438. PubMed ID: 35979901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial to assess the pharmacodynamics and pharmacokinetics of a single dose of an extended-release aspirin formulation.
    Patrick J; Dillaha L; Armas D; Sessa WC
    Postgrad Med; 2015 Aug; 127(6):573-80. PubMed ID: 25998572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of a new oral buffered acetylsalicylic acid (ASA) formulation in comparison with plain ASA in healthy volunteers.
    Viganò G; Garagiola U; Gaspari F
    Int J Clin Pharmacol Res; 1991; 11(3):129-35. PubMed ID: 1809699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and relative bioavailability of a new chewable, buffered acetylsalicylic acid tablet formulation in comparison to a conventional plain tablet.
    Lücker PW; Wetzelsberger N; Schettler T; Rogalla K
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):805-11. PubMed ID: 1297896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics and pharmacokinetics of a novel, low-dose, soft-gel capsule of acetylsalicylic acid in comparison with an oral solution after single-dose administration to healthy volunteers: a phase I, two-way crossover study.
    Loprete L; Leuratti C; Scarsi C; Radicioni M
    Clin Drug Investig; 2014 Jan; 34(1):19-25. PubMed ID: 24132773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orally given gastroprotective capsaicin does not modify aspirin-induced platelet aggregation in healthy male volunteers (human phase I examination).
    Sandor B; Papp J; Mozsik G; Szolcsanyi J; Keszthelyi Z; Juricskay I; Toth K; Habon T
    Acta Physiol Hung; 2014 Dec; 101(4):429-37. PubMed ID: 25532954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of the antiplatelet combination aspirin (acetylsalicylic acid) plus extended-release dipyridamole are not altered by coadministration with the potent CYP2C19 inhibitor omeprazole.
    Offman E; Schobelock MJ; Brickl R; VanderMaelen CP; Ehrlich J; Eisert W
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):113-20. PubMed ID: 23532686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability of rapidly dispersing, plain, and microencapsuled acetylsalicylic acid tablets after single dose administration.
    Siegmund W; Hoffmann C; Zschiesche M; Steinijans VW; Sauter R; Krüger WD; Diedrich F
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):133-8. PubMed ID: 9562228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absorption of acetylsalicylic acid from an enteric-coated formulation and the inhibition of thromboxane formation.
    Anttila M; Kahela P; Uotila P
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):88-92. PubMed ID: 3410591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of aspirin following effervescent and enteric coated tablets, and their effect on platelet function.
    Ross-Lee LM; Elms MJ; Cham BE; Bochner F; Bunce IH; Eadie MJ
    Eur J Clin Pharmacol; 1982; 23(6):545-51. PubMed ID: 7160424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
    Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
    Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover study.
    Franchi F; Schneider DJ; Prats J; Fan W; Rollini F; Been L; Taatjes-Sommer HS; Bhatt DL; Deliargyris EN; Angiolillo DJ
    J Thromb Thrombolysis; 2022 Oct; 54(3):373-381. PubMed ID: 36036856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid.
    Haastrup PF; Grønlykke T; Jarbøl DE
    Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):212-5. PubMed ID: 25469781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and safety of a fixed-dose combination of acetylsalicylic acid and clopidogrel compared with the concurrent administration of acetylsalicylic acid and clopidogrel in healthy subjects: a randomized, open-label, 2-sequence, 2-period, single-dose crossover study.
    Jung JA; Kim TE; Kim JR; Kim MJ; Huh W; Park KM; Lee SY; Ko JW
    Clin Ther; 2013 Jul; 35(7):985-94. PubMed ID: 23870608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.